Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 9, 2026

Hyperscale Data Centers Market Set to Reach US$ 177.58 Billion by 2032 | AI Workloads and Cloud Expansion Reshape Global Infrastructure Says Astute Analytica

View original at globenewswire.com
Hyperscale Data Centers Market Set to Reach US$ 177.58 Billion by 2032 | AI Workloads and Cloud Expansion Reshape Global Infrastructure Says Astute Analytica Chicago, Feb…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Daily content creation is projected to reach 463 exabytes within the next five years

    80% confidence
  • The global hyperscale data center market is expected to reach US$ 177.58 billion by 2032

    80% confidence
  • Connected devices worldwide are expected to reach 14.4 billion globally

    80% confidence
  • CRAC and CRAH units are anticipated to generate revenues exceeding US$1.36 billion by 2032, growing at a CAGR of approximately 2.24%

    80% confidence
  • The global hyperscale data center market was valued at US$ 111.57 billion in 2023

    80% confidence
  • The hyperscale data center market will grow at a CAGR of 5.3% during the forecast period 2024-2032

    80% confidence
  • The air-based cooling segment's revenue is projected to exceed US$ 1.36 billion by 2032

    80% confidence
  • More than 60% of data centers worldwide still rely on air-based cooling systems as of 2023

    80% confidence
  • Approximately 45 new hyperscale facilities are under development in the United States, each boasting power capacities of around 15 megawatts

    80% confidence
  • Global data generation reached an estimated 175 zettabytes (ZB) by 2023

    80% confidence
  • North America is projected to command over 45% of the total hyperscale data center market revenue share by the end of the forecast period

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com